GL1X · GenesisL1 explorer

MolNFT v1 · #99605 · protein

Crystal structure of human retinoid X receptor alpha-ligand binding domain complex with (S) 4-methyl 9CUAB30 coactivator peptide grip-1

4M8E · Retinoic acid receptor rxr-alpha: “Crystal structure of human retinoid X receptor alpha-ligand binding domain complex with (S) 4-methyl 9CUAB30…”. X-ray diffraction, 1 ligand (29V), 2 pockets (best druggability 0.84). MolNFT v1…

PDB
4M8E
Type
protein
Length
225 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor rxr-alpha; Nuclear receptor coactivator 2
UniProt
P19793, Q15596
Ligands
29V
Pockets
2 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor rxr-alphaprotein21468% helix, 3% strandP19793
BNuclear receptor coactivator 2protein1164% helix, 0% strandQ15596

Ligands and binding sites

  • 29V · (3E,6Z,8E)-3,7-dimethyl-8-[(4S)-4-methyl-3,4-dihydronaphthalen-1(2H)-ylidene]octa-3,6-dienoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12170.840.963829V
21550.420.7424empty

Interfaces

1 interface between chains.

  • A–B · 592 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 4M8E · CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.